MTT-Based Assessment of the Anticancer Potential of a Known 1,2-Disubstituted Benzimidazole Compound on DLD-1 Cell Line
Abstract
In this study, the cytotoxic effect of 1-(4-methylbenzyl)-2-p-tolyl-1H-benzo[d]imidazole (SL-13) was investigated on human colorectal cancer DLD-1 cells using the MTT assay. Treatment with SL-13 at various concentrations (100, 50, and 25 µM) for 72 hours resulted in a potent cytotoxic response with an IC₅₀ value of 6.093 µM, indicating strong antiproliferative activity. This potency surpasses that reported for many other benzimidazole derivatives tested against DLD-1 cells. These findings show that SL-13 is a promising candidate for further development in colorectal cancer therapy, warranting additional mechanistic and in vivo studies to elucidate its therapeutic potential.
Keywords
Supporting Institution
Süleyman Demirel University
Project Number
TSG-2024-9516
Ethical Statement
As this research was conducted entirely on established cancer cell lines, ethics committee approval was not required.
Thanks
SA would like to thank the Suleyman Demirel University Research Fund for financial support with project number TSG-2024-9516.
References
- Ahmad, N., Azad, M., Khan, A., & Azad, I. (2021). Benzimidazole as a promising antiviral heterocyclic Scaffold: A review. Journal of Science and Arts, 21(1), 273–284.
- Akkoc, S., Kayser, V., İlhan, İ. Ö., Hibbs, D. E., Gök, Y., Williams, P. A., ... & Lai, F. (2017). New compounds based on a benzimidazole nucleus: synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines. Journal of Organometallic Chemistry, 839, 98-107.
- Akkoc, S., Sahin, D., Muhammed, M. T., Yıldız, M., & Ilhan, I. O. (2023). Synthesis, characterization, antiproliferative activity, docking, and molecular dynamics simulation of new 1,3-dihydro-2H-benzimidazol-2-one derivatives. Journal of Biomolecular Structure and Dynamics, 42(21), 11495–11507.
- Akkoç, S. (2021). Design, synthesis, characterization, and in vitro cytotoxic activity evaluation of 1, 2‐disubstituted benzimidazole compounds. Journal of Physical Organic Chemistry, 34(1), e4125.
- Al-Douh, M. H., Sahib, H. B., Osman, H., Abd Hamid, S., & Salhimi, S. M. (2012). Anti-proliferation effects of benzimidazole derivatives on HCT-116 colon cancer and MCF-7 breast cancer cell lines. Asian Pacific journal of cancer prevention : APJCP, 13(8), 4075–4079.
- Al-Nasser, S., Abdulla, M. H., Alhassan, N., Vaali-Mohammed, M. A., Al-Omar, S., Hamdi, N., Elnakady, Y., Matou-Nasri, S., & Mansour, L. (2024). A Benzimidazole-Based N-Heterocyclic Carbene Derivative Exhibits Potent Antiproliferative and Apoptotic Effects against Colorectal Cancer. Medicina (Kaunas, Lithuania), 60(9), 1379.
- Ansari, K. F., & Lal, C. (2009). Synthesis and evaluation of some new benzimidazole derivatives as potential antimicrobial agents. European journal of medicinal chemistry, 44(5), 2294–2299.
- Bayar, I., Turkmenoglu, B., & Akkoc, S. (2024). Biological and in Silico Studies on the Benzimidazole-Based Compounds. Chemistry Africa, 7(5), 2345-2352.
- Bui, H. T. B., Htoo, Z. P., Hong, Q. V., Le, H. T., Tran, Q., Hnin, S. Y. Y., Do, K. M., & Morita, H. (2024). Facile Synthesis of 1,2-Disubstituted Benzimidazoles as Potent Cytotoxic Agents. Chemical & pharmaceutical bulletin, 72(11), 944–949.
- Dienstmann, R., Rodon, J., Barretina, J., & Tabernero, J. (2013). Genomic medicine frontier in human solid tumors: prospects and challenges. Journal of Clinical Oncology, 31(15), 1874-1884.